3 hours Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded at StockNews.comMarketBeat
StockNews.com upgraded shares of Arrowhead Pharmaceuticals to a “sell” rating in a research report on Thursday.
Nasdaq 100 · Pharmaceuticals · Science
XStockNews.com upgraded shares of Arrowhead Pharmaceuticals to a “sell” rating in a research report on Thursday.
Nasdaq 100 · Pharmaceuticals · Science
X